11.11.2009 • News

Markus Eckert Succeeds Bernhard Wehling

Dr. Markus Eckert
Dr. Markus Eckert
Dr. Bernhard Wehling
Dr. Bernhard Wehling

Dr. Markus Eckert will assume global responsibility for the leather chemicals business of specialty chemicals group Lanxess. The current head of the Corporate Development group function will succeed Dr. Bernhard Wehling, who is to begin the passive phase of his senior part-time working plan on this date.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read